Developing and Strengthening Cannabis Warnings: Warning Message Testing

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of North Carolina, Chapel Hill

About this trial

The purpose of this activity is to identify promising cannabis warning messages from different themes. Participants will be adults who live in the United States, including both people who use cannabis and those who do not use cannabis. In an online within-subjects experiment, participants will be randomly assigned to view 7 cannabis warning messages from different themes developed as part of previous study activities. After viewing each cannabis warning message, participants will rate the message on awareness, clarity, believability, cognitive elaboration, perceived message effectiveness, and reactance. The survey will take 15-20 minutes.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age 18 years of age and older

Live in the United States

Disqualifiers

Age less than 18 years of age

Does not live in the United States

Trial design

Design model

Single group

Treatments tested in this trial

  • Constituents

    Behavioral

    Participants will view and rate a message about constituents.

  • Cognitive Functioning

    Behavioral

    Participants will view and rate a message about cognitive functioning.

  • Cardiovascular Health

    Behavioral

    Participants will view and rate a message about cardiovascular health.

  • Motor Vehicle Crashes

    Behavioral

    Participants will view and rate a message about motor vehicle crashes.

  • Dependence

    Behavioral

    Participants will view and rate a message about dependence.

  • Psychosis and Schizophrenia

    Behavioral

    Participants will view and rate a message about psychosis and schizophrenia.

  • Mental Health

    Behavioral

    Participants will view and rate a message about mental health.

  • Reproductive Health

    Behavioral

    Participants will view and rate a message about reproductive health.

  • Respiratory Health

    Behavioral

    Participants will view and rate a message about respiratory health.

  • Edibles

    Behavioral

    Participants will view and rate a message about edibles.

  • Cannabis Hyperemesis Syndrome

    Behavioral

    Participants will view and rate a message about cannabis hyperemesis syndrome.

  • Control

    Behavioral

    Participants will view and rate a control message.

Treatment groups

1,500 Participants
are divided into 1 treatment group
Group A: Cannabis warning messagesExperimental treatment 12 interventions

Trial outcomes

Primary outcomes

1

Cognitive Elaboration

A one item measure of cognitive elaboration to assess how much a message makes the participant think about the health risks of cannabis. Response options are on a 5-point scale from 5='A great deal' to 1= 'Not at all', with higher scores indicating higher cognitive elaboration.

Time frame
Baseline (one time online survey)

Secondary outcomes

1

Perceived Message Effectiveness

This survey item assesses perceived message effectiveness in terms of how concerned the message makes the participant feel about the health effects of using cannabis. Response options are on a 5-point scale from 5='A great deal' to 1='Not at all' with higher scores indicating higher perceived message effectiveness.

Time frame
Baseline (one time online survey)

Other outcomes

1

Clarity

This survey item assesses the extent to which a participant feels that the message is clear. Response options are on a 5-point scale from 5='Very clear' to 1='Not clear at all' with higher scores indicating that a message is more clear.

Time frame
Baseline (one time online survey)
2

Believability

This survey item assesses the extent to which a participant feels that the message is believable. Response options are on a 5-point scale from 5='Very believable' to 1='Not at all believable' with higher scores indicating that a message is more believable.

Time frame
Baseline (one time online survey)
3

Reactance

This survey item assesses reactance in terms of how much a participant is annoyed by the message. Response options are on a 5-point scale from 5='A great deal' to 1='Not at all' with higher scores indicating higher reactance to the message.

Time frame
Baseline (one time online survey)

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of North Carolina, Chapel Hill

Lead sponsor

National Institute on Drug Abuse (NIDA)

Collaborator

This trial is not recruiting at the moment. You can still explore other options: